Price
$2.77
Decreased by -2.81%
Dollar volume (20D)
29.66 K
ADR%
8.09
Earnings report date
Aug 12, 2024
Shares float
11.02 M
Shares short
767.00 [0.01%]
Shares outstanding
36.15 M
Market cap
103.04 M
Beta
0.83
Price/earnings
N/A
20D range
2.45 3.22
50D range
2.26 3.85
200D range
1.90 4.48

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide.

It develops its products using its proprietary bacteriophage-based technology.

The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.

It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents.

The company is headquartered in Los Angeles, California.

Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 7, 24 -0.69
Decreased by -72.50%
-0.31
Decreased by -122.58%
Mar 21, 24 -0.55
Decreased by -89.66%
-0.35
Decreased by -57.14%
Nov 14, 23 -0.75
Decreased by -212.50%
-0.31
Decreased by -141.94%
Aug 14, 23 -0.10
Increased by +61.54%
-0.37
Increased by +72.97%
May 11, 23 -0.40
Decreased by -33.33%
-0.32
Decreased by -25.00%
Mar 16, 23 -0.29
Decreased by -26.09%
-0.28
Decreased by -3.57%
Nov 9, 22 -0.24
Decreased by -9.09%
-0.28
Increased by +14.29%
Aug 11, 22 -0.26
Decreased by -4.00%
-0.23
Decreased by -13.04%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 966.00 K
Increased by +21.36%
-25.02 M
Decreased by -41.89%
Decreased by -2.59 K%
Decreased by -16.92%
Dec 31, 23 1.53 M
Increased by +45.39%
-19.85 M
Decreased by -92.67%
Decreased by -1.30 K%
Decreased by -32.52%
Sep 30, 23 1.23 M
Decreased by -8.45%
-31.16 M
Decreased by -262.13%
Decreased by -2.54 K%
Decreased by -295.53%
Jun 30, 23 980.00 K
Decreased by -47.96%
-3.55 M
Increased by +61.49%
Decreased by -361.94%
Increased by +26.00%
Mar 31, 23 796.00 K
Increased by +N/A%
-17.63 M
Decreased by -101.00%
Decreased by -2.22 K%
Decreased by N/A%
Dec 31, 22 1.05 M
Increased by +49.06 K%
-10.30 M
Decreased by -70.35%
Decreased by -980.11%
Increased by +99.65%
Sep 30, 22 1.34 M
Increased by +106.85 K%
-8.61 M
Decreased by -58.79%
Decreased by -643.12%
Increased by +99.85%
Jun 30, 22 1.88 M
Increased by +61.22%
-9.21 M
Decreased by -48.69%
Decreased by -489.11%
Increased by +7.77%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY